CDMRP: Prostate Cancer (PC) Research Program (PCRP)

FY22 PCRP Overarching Challenges:

• Improve quality of life to enhance outcomes and overall health and wellness for those impacted by PC
• Develop treatments that improve outcomes for men with lethal PC
• Advance health equity and reduce disparities in PC
• Define the biology of PC progression to lethal prostate cancer to reduce death

Applications must be directly related to high-risk, very high-risk, and metastatic prostate cancer. Ffor risk assessment definitions see: www.nccn.org/patients/guidelines/content/PDF/prostate-advanced-patient.pdf

Various Award mechanisms and funding levels with various LOI or pre-proposal deadlines, beginning from 2.6.

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=431102

https://ebrap.org/eBRAP/public/ViewFileTemplate.htm?fileTemplateId=10409279&fileType=pdf